Patent · US Active

MiR-124 regulated genes and pathways as targets for therapeutic intervention

US8071562B2 · kind B2 · utility

31Cited by

124References

11Claims

0Family size

Assignee

MIRNA THERAPEUTICS, INC. · US

Inventors

Andreas Bader · Wiesloch, DE
Jason F. Wiggins · Austin, US
Lubna Patrawala · Cambridge, US
Kevin Kelnar · Kyle, US
Mike Byrom · Austin, US
David Brown · Brighton, US

Key dates

Filing date	Dec 1, 2008
Grant date	Dec 6, 2011
Priority date	—
Expiry date	Jan 13, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2330/10
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention concerns methods and compositions for identifying genes or genetic pathways modulated by miR-124, using miR-124 to modulate a gene or gene pathway, using this profile in assessing the condition of a patient and/or treating the patient with an appropriate miRNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.